Dear ,

HSS is proud to celebrate 160 years of getting people back to what they need and love to do. For 160 years, our doctors, clinicians, and scientists have worked tirelessly to help improve mobility and quality of life for the many people worldwide who suffer from musculoskeletal issues. But, we could not do this important work without generous donors and friends like you.

Movement fuels a world of possibility. Your unwavering partnership enables HSS to advance research, establish enduring support through endowments, and set new standards across the field of musculoskeletal medicine, which I hope you enjoy reading about in this issue of HSS Insider. Thank you for your trust and confidence in us. 

With gratitude,
Catherine Callagy
Chief Development Officer

Announcements & Updates  

Historic Leadership Transition at HSS

Bryan T. Kelly, MD, MBA will succeed President and Chief Executive Officer Lou Shapiro in a phased transition over the course of 2023, becoming the first surgeon to lead the 160-year-old academic medical system specialized in musculoskeletal health. Lou will remain as CEO during the transition period, after which Dr. Kelly will become President and CEO. Douglas E. Padgett, MD, has been appointed Surgeon-in-Chief and Medical Director when Dr. Kelly transitions to CEO later this year. Dr. Padgett is Chief Emeritus of the Adult Reconstruction and Joint Replacement Service at HSS, and a Professor of Orthopedic Surgery at Weill Cornell Medical College. 

Paving the Way for Better Care 
HSS Surgeons Assist in Development of First-Ever ACL Reconstruction Device for Children 

The FDA has provided clearance for use of the first-ever device for reconstructing torn knee ligaments in children and adolescents. This device, developed with the help of HSS sports medicine surgeon Frank Cordasco, MD, MS (pictured left), and pediatric orthopedic surgeon Daniel Green, MD, MS, FAAP, FACS (pictured right), is designed to address knee injuries in younger skeletally immature athletes and high-risk young athletes, allowing surgeons to utilize minimally invasive techniques to diminish damage while performing a successful reconstruction. 

 Philanthropy 

Moving Orthopedic Research Forward

HSS is pleased to share the 2022-2023 Endowed Chairs, Professorships, and Fellowships: Advancing the Frontiers of Medicine brochure, which powerfully demonstrates the breadth of clinical and research expertise at HSS. It also highlights the incredible commitment from our donor community to ensure that we have the resources we need to improve the lives of our patients and make meaningful contributions to our field.

News Highlights

At this year’s American Academy of Orthopaedic Surgeons (AAOS) Annual Meeting, HSS presented new research on a variety of topics in orthopedic surgery, including studies related to minimally invasive surgery, racial disparities, and opioid alternatives for pain management in spine care. A research team led by HSS Research Institute, in collaboration with Weill Cornell Medicine, has been awarded two grants to conduct groundbreaking research regarding lupus flares in an effort to discover better treatment options. 3dMD camera techonology used at HSS helps spine surgeons determine the optimal approach to operative treatments and allows them to better track the progress of scoliosis patients following surgery.  MAKE A GIFT TO HSS     PRIVACY POLICY     UNSUBSCRIBE If you wish to have your name removed from lists used for fundraising requests to support Hospital for Special Surgery, please emaildevelopment@hss.edu, call 844-810-1321(a toll-free phone number), or send a request to Hospital for Special Surgery, Development Department, 535 East 70th Street, New York, NY 10021